PATTI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 26.862
AS - Asia 15.893
EU - Europa 13.056
SA - Sud America 2.839
AF - Africa 1.486
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 21
AN - Antartide 1
Totale 60.182
Nazione #
US - Stati Uniti d'America 25.802
SG - Singapore 8.278
CN - Cina 4.213
RU - Federazione Russa 4.053
IE - Irlanda 2.446
BR - Brasile 2.369
IT - Italia 1.927
UA - Ucraina 1.692
VN - Vietnam 1.206
FR - Francia 864
CA - Canada 851
KR - Corea 678
CI - Costa d'Avorio 539
DE - Germania 473
NG - Nigeria 424
SE - Svezia 323
BD - Bangladesh 315
IN - India 313
GB - Regno Unito 310
FI - Finlandia 242
NL - Olanda 166
AR - Argentina 152
SN - Senegal 152
ZA - Sudafrica 127
MX - Messico 118
PL - Polonia 114
HK - Hong Kong 105
IQ - Iraq 99
TR - Turchia 94
CH - Svizzera 83
EC - Ecuador 80
AT - Austria 75
ES - Italia 67
UZ - Uzbekistan 64
JP - Giappone 63
PK - Pakistan 61
VE - Venezuela 59
ID - Indonesia 56
BJ - Benin 54
CO - Colombia 51
CL - Cile 46
MA - Marocco 39
EG - Egitto 37
GR - Grecia 37
LB - Libano 35
SA - Arabia Saudita 34
TN - Tunisia 31
CZ - Repubblica Ceca 30
KE - Kenya 30
PY - Paraguay 28
IR - Iran 27
PE - Perù 25
AE - Emirati Arabi Uniti 24
BG - Bulgaria 24
JO - Giordania 23
JM - Giamaica 22
BE - Belgio 21
EU - Europa 21
IL - Israele 21
AZ - Azerbaigian 20
MY - Malesia 20
NP - Nepal 19
PH - Filippine 19
AU - Australia 17
DZ - Algeria 17
LT - Lituania 16
HR - Croazia 15
OM - Oman 13
UY - Uruguay 13
DO - Repubblica Dominicana 12
ET - Etiopia 12
KZ - Kazakistan 12
AL - Albania 11
BO - Bolivia 11
CR - Costa Rica 11
PS - Palestinian Territory 11
TH - Thailandia 11
KG - Kirghizistan 10
PA - Panama 10
BH - Bahrain 9
RO - Romania 9
HN - Honduras 8
LV - Lettonia 7
RS - Serbia 7
BA - Bosnia-Erzegovina 6
CG - Congo 6
GE - Georgia 6
HU - Ungheria 6
PT - Portogallo 6
BB - Barbados 5
MD - Moldavia 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AM - Armenia 4
GT - Guatemala 4
KW - Kuwait 4
LK - Sri Lanka 4
SV - El Salvador 4
AO - Angola 3
BW - Botswana 3
Totale 60.109
Città #
Dallas 5.198
Singapore 4.496
Santa Clara 2.570
Dublin 2.433
Chandler 2.034
San Jose 2.009
Jacksonville 1.819
Moscow 1.583
Ashburn 1.433
Boardman 1.036
Hefei 872
Nanjing 705
Lauterbourg 690
Seoul 675
Cambridge 657
Lawrence 656
Andover 644
Chicago 583
Toronto 578
Abidjan 539
Los Angeles 420
Catania 399
Ho Chi Minh City 397
Des Moines 328
Beijing 325
Houston 300
Hanoi 267
Council Bluffs 266
San Mateo 253
Wilmington 239
Nanchang 219
Abuja 205
New York 205
Civitanova Marche 196
Lagos 194
São Paulo 189
Munich 187
Shenyang 179
Hebei 160
Buffalo 155
Dakar 152
Ottawa 151
Saint Petersburg 147
Changsha 137
Jiaxing 135
Tianjin 131
Helsinki 125
Lappeenranta 97
Orem 92
Hong Kong 90
Amsterdam 87
Johannesburg 75
Milan 75
Pune 75
Rome 75
Rio de Janeiro 73
Warsaw 71
Dong Ket 69
Bremen 67
London 66
Grafing 63
Seattle 60
San Francisco 59
Brooklyn 57
Phoenix 57
The Dalles 55
Cotonou 54
Stockholm 54
Tokyo 54
Denver 53
Norwalk 53
Columbus 52
Washington 51
Chennai 50
Jinan 50
Montreal 50
Palermo 48
Redondo Beach 48
Belo Horizonte 47
Brasília 46
Da Nang 46
Haiphong 46
Poplar 42
Naples 41
Baghdad 39
Boston 39
Zhengzhou 39
Curitiba 38
Manchester 38
Porto Alegre 36
Frankfurt am Main 35
Atlanta 34
Hangzhou 34
Mexico City 34
Guangzhou 33
Ningbo 33
Dhaka 31
Den Haag 30
Mumbai 29
Nuremberg 29
Totale 40.070
Nome #
6. Efficacy of a computer-assisted cognitive rehabilitation protocol on walking in Parkinson's disease patients with freezing of gait: a pilot study 298
A case of multiple autoimmunity complicated by SIADH 296
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations 221
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 170
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 164
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 163
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 162
Management of dysphagia in multiple sclerosis: current best practice 159
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study 159
An update on the safety of treating relapsing-remitting multiple sclerosis 152
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 151
"Valutazione della efficacia terapeutica di un derivato benzamidico (Tiapride) in alcune sindromi di interesse neurologico". 150
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 150
Altered time course of changes in the hippocampal concentration of excitatory and inhibitory amino acids during kainate-induced epilepsy 150
Computer-assisted cognitive rehabilitation on freezing of gait in Parkinson's disease: A pilot study 145
An update on the pharmacological management of pain in patients with multiple sclerosis 145
"Effetti della somministrazione cronica di Aloperidolo e Sulpiride sul contenuto di GABA nella Substantia Nigra del ratto". 144
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS 142
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated 142
"BoNT/A treatment of Sialorrohea following neurological disorders 141
A waves in electroneurography: differential diagnosis with other late responses 141
Neurophysiological tests in Multiple Sclerosis. A synthetic overview. 140
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 139
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 139
Cognitive dysfunction in multiple sclerosis. A population based study in Catania, Sicily 137
Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy 137
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 134
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 132
Can new chemical therapies improve the management of multiple sclerosis in children? 131
"Valutazione del behaviour motorio in condizioni di iperprolattinemia". 131
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 131
"Comparative effects of estrogens and Prolactin on nigro-striatal DAergic system: neurochemical and behavioral findings". 130
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 130
Analisi del cammino di bambini con paralisi cerebrale infantile: modificazioni della cinetica della caviglia dopo trattamento con tossina botulinica di tipo A 129
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 129
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 129
"Influenza del sistema dopaminergico centrale sulla attivita' GABAergica del cervelletto". 128
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal. 126
Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review 125
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 125
CCSVI and MS. A population-based case-control study in Catania, Sicily. 125
"Convulsioni sperimentali indotte da iniezioni di acido Kainico nei nuclei cerebellari". 124
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 124
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 124
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 123
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily: an update 123
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily 123
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement 123
Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study 123
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 123
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 122
Personalized therapy in multiple sclerosis: an Italian Delphi consensus 122
A case of Marburg variant multiple sclerosis: clinical impact after high dose cyclophosphamide treatment 121
Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case control study 121
Epilepsy and multiple sclerosis 120
"Comparative effect of chronic Haloperidol and Sulpiride treatment on nigral and striatal GABA content". 120
"Calcitonina and nigro-striatal system: neurochemical, behavioural and clinical data". 120
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily. 120
Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry 118
"Modulazione del sistema dopaminergico nigro-striatale da parte di estrogeni e Prolattina: dati comportamentali e neurochimici". 118
Paediatric multiple sclerosis: A scoping review of patients’ and parents’ perspectives 118
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 118
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany 116
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis 116
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 115
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 115
"Calcitonin effects on extrapyramidal system: clinical and experimenta data". 115
"La distonia: correlazione tra blink reflex e trattamento farmacologico con Reserpina". 115
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 115
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 115
The impact of outpatient rehabilitation on quality of life in multiple sclerosis 114
"Effects of Hyper and Hypoprolactinemia on glutamate decarboxilase activity in medial basal Hypothalamus of male rat". 114
Clinical Evolution of Relapsing Remitting Late Onset Multiple Sclerosis: A Nine Year Follow-Up Study 114
Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study 114
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 114
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 113
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 112
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 112
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 112
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 112
Environmental and occupational exposure to heavy metals and metalloid and development of amyotrophic lateral sclerosis: a population-based case control study in Emilia-Romagna and Sicily. 111
Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives 111
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 111
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients 111
Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study 110
Didattica delle encefalopatie spongiformi 110
Multicenter, prospective, observational study aimed at evaluating SAtivex efFEcts (effectiveness and tolerability) in a large population of Italian multiple sclerosis patients: SA. FE. study 110
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 110
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 109
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 109
"Drug-use, non-use and misuse: Carbamazepine in cluster headache therapy". 108
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS 108
Lack of evidence for Toxocara infection in Italian myelitis patients 108
A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis. 108
Reply to Comment on “Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study” 108
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 107
Palliative care in multiple sclerosis 107
"Comparative effects of chronic Haloperidol and Sulpiride treatment on nigral-striatal GABA content". 107
The Rao's Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population 107
Fattori di rischio ambientali e occupazionali per la sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione in Emilia Romagna e Sicilia 107
Totale 12.950
Categoria #
all - tutte 215.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 0 0 0 0 0 0 192
2021/20224.488 552 693 30 87 703 17 683 142 360 12 153 1.056
2022/20236.985 698 208 103 493 711 1.247 34 1.237 1.833 61 262 98
2023/20242.825 178 419 152 162 115 459 80 166 33 94 622 345
2024/202511.637 99 1.576 818 382 2.348 1.066 341 519 1.094 1.524 788 1.082
2025/202627.612 1.528 2.237 4.889 1.898 4.340 4.357 3.612 778 1.336 1.380 901 356
Totale 61.353